These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21771491)

  • 1. β-adrenergic receptor subtype signaling in the heart: from bench to the bedside.
    Zhu W; Woo AY; Zhang Y; Cao CM; Xiao RP
    Curr Top Membr; 2011; 67():191-204. PubMed ID: 21771491
    [No Abstract]   [Full Text] [Related]  

  • 2. Subtype-specific beta-adrenoceptor signaling pathways in the heart and their potential clinical implications.
    Xiao RP; Zhu W; Zheng M; Chakir K; Bond R; Lakatta EG; Cheng H
    Trends Pharmacol Sci; 2004 Jul; 25(7):358-65. PubMed ID: 15219978
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of chronic heart failure with β-adrenergic receptor antagonists: a convergence of receptor pharmacology and clinical cardiology.
    Bristow MR
    Circ Res; 2011 Oct; 109(10):1176-94. PubMed ID: 22034480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-adrenergic receptors, from their discovery and characterization through their manipulation to beneficial clinical application.
    Wachter SB; Gilbert EM
    Cardiology; 2012; 122(2):104-12. PubMed ID: 22759389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocyte adrenoceptor signaling pathways.
    Xiang Y; Kobilka BK
    Science; 2003 Jun; 300(5625):1530-2. PubMed ID: 12791980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the role of beta-adrenergic signaling in heart failure?
    Lohse MJ; Engelhardt S; Eschenhagen T
    Circ Res; 2003 Nov; 93(10):896-906. PubMed ID: 14615493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct beta-adrenergic receptor subtype signaling in the heart and their pathophysiological relevance.
    Zheng M; Han QD; Xiao RP
    Sheng Li Xue Bao; 2004 Feb; 56(1):1-15. PubMed ID: 14985822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Beta-adrenergic receptors in normal and failing heart].
    Mackiewicz U; Klemenska E; Beresewicz A
    Kardiol Pol; 2007 Mar; 65(3):294-302. PubMed ID: 17436160
    [No Abstract]   [Full Text] [Related]  

  • 9. [The pathophysiological mechanism of cardiac development and hypertrophy, and heart failure].
    Hasegawa H; Komuro I
    Nihon Rinsho; 2003 May; 61(5):704-7. PubMed ID: 12754991
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic and phenotypic targeting of beta-adrenergic signaling in heart failure.
    Koch WJ
    Mol Cell Biochem; 2004 Aug; 263(1-2):5-9. PubMed ID: 15524162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure.
    Port JD; Bristow MR
    J Mol Cell Cardiol; 2001 May; 33(5):887-905. PubMed ID: 11343413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic manipulation of myocardial beta-adrenergic receptor activation and desensitization.
    Hata JA; Williams ML; Koch WJ
    J Mol Cell Cardiol; 2004 Jul; 37(1):11-21. PubMed ID: 15242731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtype-specific alpha1- and beta-adrenoceptor signaling in the heart.
    Xiao RP; Zhu W; Zheng M; Cao C; Zhang Y; Lakatta EG; Han Q
    Trends Pharmacol Sci; 2006 Jun; 27(6):330-7. PubMed ID: 16697055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gene therapy and benefits in modulating of system beta-adrenergic in cardiac insufficiency].
    Tevaearai HT; Walton GB; Koch WJ
    Rev Med Suisse Romande; 2002 Mar; 122(3):149-53. PubMed ID: 12014253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronic application of propranolol on beta-adrenergic signal transduction in heart ventricles from myopathic BIO TO2 and control hamsters.
    Witte K; Schnecko A; Hauth D; Wirzius S; Lemmer B
    Br J Pharmacol; 1998 Nov; 125(5):1033-41. PubMed ID: 9846642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic AMP-mediated signal transduction in heart failure: molecular pathophysiology and therapeutic implications.
    Movsesian MA
    J Investig Med; 1997 Oct; 45(8):432-40. PubMed ID: 9394095
    [No Abstract]   [Full Text] [Related]  

  • 17. A new regulation of IL-6 production in adult cardiomyocytes by beta-adrenergic and IL-1 beta receptors and induction of cellular hypertrophy by IL-6 trans-signalling.
    Szabo-Fresnais N; Lefebvre F; Germain A; Fischmeister R; Pomérance M
    Cell Signal; 2010 Jul; 22(7):1143-52. PubMed ID: 20227492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of beta-adrenoceptor signaling in cardiac function and disease.
    Dzimiri N
    Pharmacol Rev; 1999 Sep; 51(3):465-501. PubMed ID: 10471415
    [No Abstract]   [Full Text] [Related]  

  • 19. The control of cardiomyocyte apoptosis via the beta-adrenergic signaling pathways.
    Communal C; Colucci WS
    Arch Mal Coeur Vaiss; 2005 Mar; 98(3):236-41. PubMed ID: 15816327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential distribution of beta-1 and beta-2 adrenergic receptors in cat and guinea-pig heart.
    Hedberg A; Minneman KP; Molinoff PB
    J Pharmacol Exp Ther; 1980 Mar; 212(3):503-8. PubMed ID: 6244386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.